• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脆性X综合征中的环磷酸腺苷代谢

Cyclic AMP metabolism in fragile X syndrome.

作者信息

Berry-Kravis E, Huttenlocher P R

机构信息

Department of Pediatrics, University of Chicago, IL.

出版信息

Ann Neurol. 1992 Jan;31(1):22-6. doi: 10.1002/ana.410310105.

DOI:10.1002/ana.410310105
PMID:1371909
Abstract

Cyclic AMP (cAMP) metabolism was studied in platelets from a series of 14 patients with fragile X syndrome (fra X) and 21 control individuals. 1-Isobutyl-3-methylxanthine was used to inhibit phosphodiesterase and thus measure cAMP production, prostaglandin E1 was used to assess receptor-mediated cAMP accumulation, and forskolin was used to directly stimulate the catalytic subunit. In patients with fra X, basal production was 63% of that of control subjects (p = 0.019). Prostaglandin E1- and forskolin-stimulated production were 61% (p = 0.039) and 56% (p = 0.012) of that of control subjects, respectively. cAMP production in 8 patients with fra X overlapped the control range, whereas measures of production in 6 patients formed a cluster with values lower than any of the 21 control subjects assayed, suggesting possible biochemical heterogeneity within patients with fra X. Results obtained from the group of patients with fra X suggest possible abnormal function or regulation of the catalytic subunit of adenylate cyclase in at least a subgroup of patients with fra X. Variability of biochemical findings in patients with fra X may reflect the known high variability of the clinical syndrome.

摘要

对14名脆性X综合征(fra X)患者和21名对照个体的血小板中的环磷酸腺苷(cAMP)代谢进行了研究。使用1-异丁基-3-甲基黄嘌呤抑制磷酸二酯酶,从而测量cAMP的产生;使用前列腺素E1评估受体介导的cAMP积累;使用福斯高林直接刺激催化亚基。在fra X患者中,基础产量是对照受试者的63%(p = 0.019)。前列腺素E1和福斯高林刺激的产量分别是对照受试者的61%(p = 0.039)和56%(p = 0.012)。8名fra X患者的cAMP产量落在对照范围内,而6名患者的产量测量值形成一个集群,其值低于所检测的21名对照受试者中的任何一个,这表明fra X患者可能存在生化异质性。从fra X患者组获得的结果表明,至少在一部分fra X患者中,腺苷酸环化酶催化亚基可能存在功能异常或调节异常。fra X患者生化结果的变异性可能反映了已知的临床综合征的高变异性。

相似文献

1
Cyclic AMP metabolism in fragile X syndrome.脆性X综合征中的环磷酸腺苷代谢
Ann Neurol. 1992 Jan;31(1):22-6. doi: 10.1002/ana.410310105.
2
Demonstration of abnormal cyclic AMP production in platelets from patients with fragile X syndrome.脆性X综合征患者血小板中异常环磷酸腺苷生成的证明。
Am J Med Genet. 1993 Jan 1;45(1):81-7. doi: 10.1002/ajmg.1320450120.
3
Reduced cyclic AMP production in fragile X syndrome: cytogenetic and molecular correlations.
Pediatr Res. 1995 Nov;38(5):638-43. doi: 10.1203/00006450-199511000-00002.
4
Model of prostaglandin-regulated cyclic AMP metabolism in intact platelets: examination of time-dependent effects on adenylate cyclase and phosphodiesterase activities.完整血小板中前列腺素调节的环磷酸腺苷代谢模型:对腺苷酸环化酶和磷酸二酯酶活性的时间依赖性影响研究
Mol Pharmacol. 1989 Dec;36(6):866-73.
5
Adult fragile X syndrome: neuropsychology, brain anatomy, and metabolism.
Am J Med Genet. 1995 Dec 18;60(6):480-93. doi: 10.1002/ajmg.1320600603.
6
Neuropsychological dysfunction among affected heterozygous fragile X females.
Am J Med Genet. 1990 Jan;35(1):28-35. doi: 10.1002/ajmg.1320350107.
7
The effects of in vitro and in vivo exposure to insulin upon prostaglandin E1 stimulation of platelet adenylate cyclase activity in healthy subjects.健康受试者体外和体内暴露于胰岛素对前列腺素E1刺激血小板腺苷酸环化酶活性的影响。
Diabetes Res. 1994;27(1):39-46.
8
cAMP and human neutrophil chemotaxis. Elevation of cAMP differentially affects chemotactic responsiveness.环磷酸腺苷(cAMP)与人类中性粒细胞趋化性。cAMP水平的升高对趋化反应性有不同影响。
J Immunol. 1991 Jan 1;146(1):224-32.
9
Behavioural and emotional disturbance in fragile X syndrome.
Am J Med Genet. 1994 Jul 15;51(4):386-91. doi: 10.1002/ajmg.1320510417.
10
Increased platelet reactivity to prostaglandin E1 in hypertension is linked with altered signal transduction.高血压患者血小板对前列腺素E1的反应性增加与信号转导改变有关。
Am J Hypertens. 1993 Oct;6(10):857-62.

引用本文的文献

1
From Discovery to Innovative Translational Approaches in 80 Years of Fragile X Syndrome Research.从发现到创新转化方法:脆性X综合征80年研究历程
Biomedicines. 2025 Mar 27;13(4):805. doi: 10.3390/biomedicines13040805.
2
Therapeutic Effects of Pharmacological Modulation of Serotonin Brain System in Human Patients and Animal Models of Fragile X Syndrome.血清素脑系统的药理学调节对脆性X综合征人类患者及动物模型的治疗作用
Int J Mol Sci. 2025 Mar 11;26(6):2495. doi: 10.3390/ijms26062495.
3
Systematic Review: Fragile X Syndrome Across the Lifespan with a Focus on Genetics, Neurodevelopmental, Behavioral and Psychiatric Associations.
系统评价:全生命周期的脆性X综合征,重点关注遗传学、神经发育、行为及精神方面的关联
Genes (Basel). 2025 Jan 25;16(2):149. doi: 10.3390/genes16020149.
4
Modeling neurodegenerative and neurodevelopmental disorders in the mushroom body.在蘑菇体中模拟神经退行性和神经发育障碍。
Learn Mem. 2024 Jun 14;31(5). doi: 10.1101/lm.053816.123. Print 2024 May.
5
From wings to whiskers to stem cells: why every model matters in fragile X syndrome research.从翅膀到胡须再到干细胞:为何每种模型在脆性X综合征研究中都至关重要。
J Neurodev Disord. 2024 Jun 13;16(1):30. doi: 10.1186/s11689-024-09545-w.
6
Research progress on phosphodiesterase 4 inhibitors in central nervous system diseases.磷酸二酯酶 4 抑制剂在中枢神经系统疾病中的研究进展。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024 Jun 6;53(3):390-398. doi: 10.3724/zdxbyxb-2024-0023.
7
Characterization of a Clinically and Biologically Defined Subgroup of Patients with Autism Spectrum Disorder and Identification of a Tailored Combination Treatment.自闭症谱系障碍患者临床和生物学定义亚组的特征分析及定制联合治疗方案的确定
Biomedicines. 2024 Apr 30;12(5):991. doi: 10.3390/biomedicines12050991.
8
State-of-the-art therapies for fragile X syndrome.脆性 X 综合征的最新疗法。
Dev Med Child Neurol. 2024 Jul;66(7):863-871. doi: 10.1111/dmcn.15885. Epub 2024 Feb 22.
9
Altered brain serotonin 5-HT receptor expression and function in juvenile Fmr1 knockout mice.幼鼠 Fmr1 基因敲除模型中脑内 5-羟色胺 5-HT 受体表达和功能的改变。
Neuropharmacology. 2024 Mar 1;245:109774. doi: 10.1016/j.neuropharm.2023.109774. Epub 2023 Nov 3.
10
Targeted Treatments for Fragile X Syndrome.脆性X综合征的靶向治疗
Adv Neurobiol. 2023;30:225-253. doi: 10.1007/978-3-031-21054-9_10.